Related Experiment Video
Updated: Mar 29, 2026
06:47
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
10.0K
Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis.
Younghoon Jeon1,2, Eunjung Heo3, Xian Jin3
1Department of Anesthesiology and Pain Medicine, School of Medicine Kyungpook National University, Daegu 41944, Republic of Korea.
Marine Drugs
|March 27, 2026
Summary
Polydeoxyribonucleotide (PDRN) promotes osteoblast differentiation for bone regeneration. This study found PDRN enhances bone formation without impacting bone-resorbing osteoclasts, suggesting its potential as a novel anabolic agent.
Area of Science:
- Biochemistry
- Cell Biology
- Regenerative Medicine
Background:
- Developing new anabolic agents for bone regeneration is crucial.
- The cellular effects of Polydeoxyribonucleotide (PDRN) on bone remodeling are not fully understood.
Purpose of the Study:
- To investigate the in vitro effects of PDRN on osteoblast and osteoclast differentiation.
- To determine if PDRN influences key markers of bone formation and resorption.
Main Methods:
- Osteoblast (MC3T3-E1) and osteoclast precursor differentiation were induced.
- Cellular metabolic activity was assessed using MTS assays.
- Gene and protein expression (Runx2, osteocalcin) were analyzed via qRT-PCR and Western blotting.
- Osteoblast differentiation markers (ALP, Alizarin Red S) and osteoclast function (TRAP, pit formation) were evaluated.
Main Results:
- PDRN dose-dependently increased osteoblast metabolic activity and upregulated the transcription factor Runx2.
- PDRN significantly enhanced osteoblast differentiation, indicated by increased ALP activity, mineralized matrix deposition, and osteocalcin expression.
- PDRN did not affect osteoclast precursor proliferation, differentiation, or resorptive activity.
Conclusions:
- PDRN selectively promotes osteoblast differentiation and bone formation.
- PDRN does not directly stimulate osteoclastogenesis, suggesting a favorable anabolic profile.
- PDRN is a potential candidate for developing novel anabolic agents for bone regeneration.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
4.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.7K
01:24Bone Formation by Endochondral Ossification
13.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
13.6K
01:17Hormones and Bone Tissue
4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
01:29Bone Disorders
7.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.5K
01:30Bone Cells and Tissue
11.8K
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
11.8K
01:29Bone Formation by Intramembranous Ossification
15.4K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
15.4K